David R.W. Jayne Aurinia Pharmaceuticals Inc. (AUPH) insider trading activity

AUPH Quotes by TradingView

David R.W. Jayne is Director of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 56,499 shares of AUPH, which is worth approximately $522,615. The most recent transaction as insider was on Nov 21, 2024, when has been sold 12,135 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 56.5K
27.35% 3M change
14.58% 12M change
Total Value Held $522,615

David R.W. Jayne Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 21 2024
BUY
Grant, award, or other acquisition
-
12,135 Added 17.68%
56,499 Common Shares
May 21 2024
SELL
Open market or private sale
$28,390 $5.74 p/Share
4,946 Reduced 10.03%
44,364 Common Stock
May 23 2023
SELL
Open market or private sale
$98,333 $11.26 p/Share
8,733 Reduced 15.05%
49,310 Common Stock
May 19 2023
BUY
Grant, award, or other acquisition
-
9,310 Added 13.82%
58,043 Common Stock
May 18 2023
BUY
Exercise of conversion of derivative security
-
8,733 Added 15.2%
48,733 Common Stock
DRJ

David R.W. Jayne

Director
Victoria, A1

Track Institutional and Insider Activities on AUPH

Follow Aurinia Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

News

Receive news related to Aurinia Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AUPH